Gene Therapy Curing X-Linked Retinitis Pigmentosa in Dogs Paves the Way for Similar Treatment in Humans

March 19, 2012

Researchers at several universities and laboratories collaborated to treat dogs afflicted with the x-linked form of retinitis pigmentosa, to deliver the therapeutic RPGR gene specifically to the diseased rods and cones. This led to functional and structural recovery, and is the first proof that this condition is treatable in an animal model. The researchers concluded that the results are promising and relevant for translation to humans afflicted with this disease.

The results have been published in the journal, Proceedings of the National Academy of Sciences.

To read the full story, please follow this link.

 

 



Comments

Jump down to form below to submit your own comments

2 Responses to “Gene Therapy Curing X-Linked Retinitis Pigmentosa in Dogs Paves the Way for Similar Treatment in Humans”

  1. michael pressley on March 25th, 2012 12:49 pm

    This is great news for those of us with the blinding effects of RP. The only reservations I have will be the red tape involved with the FDA and government.
    I pray that the red tape can be cut and the human trails can soon begin.

    P.S. if Bill Gates had this disease there would already be a cure.

  2. Johan on April 5th, 2012 9:56 am

    This is fantastic news for people with RP as a result of all genes (not RPGR only)! I believe there are other gene / dog combinations which have also advanced to the same point.

    It will be some time before we see the human cure though. It needs dedicated people, time and money Anybody wants to take a guess at how long before we have a safe product?

Trackback URL
http://eyedocnews.com/006570-gene-therapy-research-in-dogs-cures-x-linked-retinitis-pigmentosa-paves-the-way-for-similar-treatment-in-humans/trackback/

Have insights to contribute? Please submit your comment below